Novo Nordisk NOVO.B-1.01%decrease; red down pointing triangle filed for U.S. Food and Drug Administration approval of ...
Dozens of felony cases have crumbled in DOJ's push to punish protesters ...
The MarketWatch News Department was not involved in the creation of this content.-- Wegovy(R) (semaglutide injection) granted conditional marketing authorization for the treatment ...
President Trump launched TrumpRx, a new initiative aiming to slash prescription drug costs by forging direct deals with ...
Eli Lilly also said it has filed for Food and Drug Administration approval of the daily GLP-1 pill, called orforglipron, for ...
A selective androgen receptor modulator combined with a GLP-1 may induce weight loss for older adults with obesity while ...
Novo Nordisk stock plunges 42% so far in 2025 as GLP-1 competition, price cuts, guidance trims and restructuring plans cloud ...